Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-06-18 @ 7:38 AM
Study NCT ID:
NCT04714827
Status:
RECRUITING
Last Update Posted:
2023-12-29
First Post:
2021-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Shanxi Province Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CAR-T SXZL03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |